Home / About / Leadership

Leadership

The foundation’s leaders come from a broad range of backgrounds and have a diversity of expertise and experience that spans science and technology, medicine, public policy, education, communications, law, and business. Our leaders are guided by the foundation’s mission to create a world in which every person has the opportunity to live a healthy, productive life.




Scientific Advisory Committee

Our Scientific Advisory Committee comprises a group of esteemed experts from outside of the foundation who offer a wide range of experiences and perspectives. This group plays an important role in strengthening our work by offering independent assessments of our Global Health Division strategies and helping us evaluate results.


Meet our leaders

37 – 45 of 58
  • Lynda Stuart

    Lynda Stuart

    Former Deputy Director, Vaccines & Human Immunology

    Dr. Lynda Stuart led the Vaccine and Host Pathogen Biology domain of the Discovery and Translational Sciences team.

  • Maike Scharp

    Maike Scharp

    Deputy Director, Diagnostics

    Dr. Maike Scharp leads the foundation’s efforts to support development of diagnostic tools and devices and end-to-end diagnostic platforms for enteric and diarrheal diseases.

  • Marlo Hartung

    Marlo Hartung

    Deputy Director, Strategy, Planning, and Management

    Marlo Hartung leads strategy implementation, financial portfolio management and business operations for the EDGE team which is focused on reducing the burden of enteric diseases and improving access to cutting edge diagnostic and disease surveillance technologies in the developing world.

  • Mike McCune

    Mike McCune

    Head of HIV Frontiers, Accelerator

    Mike McCune leads a team that works to develop novel gene-based curative interventions for HIV and sickle cell disease.

  • Murray Lumpkin

    Murray M. Lumpkin

    Deputy Director, Regulatory

    Dr. Murray (“Mac”) Lumpkin leads the Integrated Development team’s efforts to strengthen regulatory systems governing the development, marketing, and procurement of health products in low- and middle-income countries.

  • Nina Russell

    Nina Russell

    Director, TB & HIV Research and Development

    Dr. Nina Russell oversees the foundation’s investments in vaccine and drug development to prevent and treat tuberculosis (TB) and HIV.

  • Obinna Onyekwena

    Obinna Onyekwena

    Deputy Director, Infectious Diseases Advocacy, Program Advocacy & Communications

    Dr. Obinna (Obi) Onyekwena leads the foundation’s infectious disease advocacy work and its investments to advance financing and policy goals related to HIV, tuberculosis, malaria, neglected tropical diseases, and the Global Fund to Fight AIDS, Tuberculosis and Malaria.

  • Padmini Srikantiah

    Padmini Srikantiah

    Deputy Director, Pneumonia

    Dr. Padmini Srikantiah leads the foundation’s initiative to address respiratory syncytial virus, the chief cause of pneumonia in young infants globally, as well as the cross-foundation antimicrobial resistance strategy, which includes efforts to prevent newborn sepsis.

  • Pervin Anklesaria

    Pervin Anklesaria

    Deputy Director, HIV and Tuberculosis

    Pervin Anklesaria leads the HIV vaccines and biologics prevention efforts for the foundation’s HIV team.


Historical Leadership


More about the foundation

Our role

For over 25 years, the Gates Foundation has been committed to fighting the greatest inequities in the world.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.

Our story

Learn about the origins of the foundation and the values that drive our work.